Site Search

... D.C. –  The administration released its FY20 budget today including a $4.7 billion cut for medical research at the National Institutes of Health (NIH) including a nearly $900 million cut for the National Cancer Institute (NCI). The budget also reduces funding by $34.5 million for ... use. However, FDA’s urgent regulatory work to address this crisis should not be dependent on the assessment of this fee.   Access to Care “Capping out-of-pocket prescription costs for seniors on Medicare Part D and allowing some low-income enrollees to be spared cost-sharing on ... their care. “However, transforming Medicaid funding into a block grant would likely leave millions of Americans unable to access critical health services. Medicaid serves as an essential safety-net for more than 2.3 million Americans with a history of cancer, including one-third of ...

... case, Relentless v. Dept. of Commerce. The cases put in question the “Chevron deference” that protects the legal stability of public health programs like Medicare and Medicaid that benefit nearly half of the U.S. population by ensuring that laws passed by Congress can continue to be interpreted and implemented by expert federal agencies such as the Centers for Medicare and Medicaid Services (CMS).   National health groups filed an amicus brief in September noting their concern, providing real-world examples of how the Chevron deference keeps the legal ... urge the Supreme Court to uphold the long-standing Chevron precedent and ensure the continued stability and strength of our nation’s health care system that serves millions with cancer and other chronic diseases.”  The above statement is on behalf of the American Cancer Society ...

... vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s numerous provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out ... A portion of the bill’s estimated savings would be directed to increasing federal investment in medical research at the National Institutes of Health (NIH) and extending funding for the Cancer Moonshot Initiative at the National Cancer Institute (NCI). The following is a statement from ... a cancer drug in 2017 hit the catastrophic cap in just the first two months of the year, according to research done for ACS CAN by Avalere Health. Rather than requiring full payment upfront, we support allowing those patients with high-cost drugs to space out their prescription drug ...

... It also leaves patients with a long list of concerns, including whether they’ll be able to afford the treatment ahead. “Out-of-pocket health-care costs are on the rise, with some Oklahomans unable to access the life-saving treatments and medications recommended by their providers. Far ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and made workplaces, including restaurants and bars, smoke-free. As we mark our 20th anniversary, we’re more determined than ever ...